Masahiko Matsuo Selected Research

Masahiko Matsuo Research Topics

6	Vomiting 01/2014 - 05/2002
6	Neoplasms (Cancer) 05/2006 - 05/2002
2	Atherosclerosis 02/2005 - 10/2004
1	Glomerulonephritis 11/2005
1	Proteinuria 11/2005
1	Renal Insufficiency (Renal Failure) 11/2005
1	Motion Sickness (Airsickness) 08/2005
1	Pica (Geophagia) 11/2004
1	Kidney Neoplasms (Kidney Cancer) 09/2003
1	Hypoxia (Hypoxemia) 09/2003
1	Hypercholesterolemia 12/2002
1	Lymphoma (Lymphomas) 10/2002
1	Lewis Lung Carcinoma 07/2002
1	Melanoma (Melanoma, Malignant) 07/2002

6	Cisplatin (Platino)FDA LinkGeneric 01/2014 - 05/2002
5	AntiemeticsIBA 01/2014 - 05/2002
3	Copper Sulfate (Sulfate, Copper)FDA Link 01/2014 - 11/2004
3	EmeticsIBA 01/2014 - 05/2002
3	Apomorphine FDA Link 01/2013 - 05/2002
3	romidepsin (FK228)FDA Link 09/2003 - 10/2002
3	Histone Deacetylase InhibitorsIBA 09/2003 - 10/2002
3	DepsipeptidesIBA 09/2003 - 10/2002
2	FK886IBA 01/2014 - 01/2013
2	Neurokinin-1 Receptor AntagonistsIBA 01/2014 - 01/2013
2	Granisetron (Kytril)FDA LinkGeneric 05/2006 - 08/2005
2	Apolipoproteins E (ApoE)IBA 02/2005 - 10/2004
2	Triglycerides (Triacylglycerol)IBA 02/2005 - 10/2004
2	ApolipoproteinsIBA 02/2005 - 10/2004
2	Histones (Histone)IBA 09/2003 - 10/2002
2	Messenger RNA (mRNA)IBA 09/2003 - 06/2003
1	zacoprideIBA 05/2006
1	5-HT4 Serotonin ReceptorsIBA 05/2006
1	Captopril (Capoten)FDA LinkGeneric 11/2005
1	anti-Thy antibodyIBA 11/2005
1	Monoclonal AntibodiesIBA 11/2005
1	FK 1052IBA 08/2005
1	Caspase 9IBA 02/2005
1	microsomal triglyceride transfer proteinIBA 02/2005
1	implitapideIBA 02/2005
1	LipidsIBA 02/2005
1	Loperamide (Imodium)FDA LinkGeneric 11/2004
1	diphenidol (Vontrol)FDA Link 11/2004
1	Orlistat (Xenical)FDA Link 10/2004
1	Lipase (Acid Lipase)FDA Link 10/2004
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2003
1	CholesterolIBA 12/2002
1	Acetates (Acetic Acid Esters)FDA Link 07/2002
1	Trientine (Trien)FDA Link 07/2002
1	Mitomycin (Mitomycin-C)FDA LinkGeneric 07/2002
1	Capsaicin (Zostrix)FDA Link 05/2002
1	resiniferatoxinIBA 05/2002

5	Drug Therapy (Chemotherapy) 01/2014 - 05/2002
2	Oral Administration 01/2014 - 08/2005
2	Intravenous Injections 05/2006 - 08/2005
1	Intravenous Administration 01/2014